Notch is an early-stage biotech company, working to maximize the benefit of cell therapies through a proprietary T cell-production platform which combines sophisticated product design with commercial-compatible processes to enhance patient outcomes. Notch’s iPSC-based technology platform allows for precision control of notch signaling, which removes several critical limiting factors in the development of cell therapies, delivering the ability to design and manufacture a uniform and unlimited supply of therapeutic T cells.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 887 Great Northern Way, 500,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- notchtx.com
- HQ
- Vancouver, British Columbia
Notch Therapeutics Questions
Notch Therapeutics's website is notchtx.com
Notch Therapeutics's LinkedIn profile is https://www.linkedin.com/company/notchtx
Notch Therapeutics has
24 employees.
View email and phone details for 24
employees at Notch Therapeutics.
Notch Therapeutics's industry is
Biotechnology Research
Notch Therapeutics's top competitors are
Aspect Biosystems,
Omniabio,
Bluerock Therapeutics,
Xenon Pharmaceuticals Inc.,
Ccrm,
Acuitas Therapeutics,
Abcellera,
Stemcell Technologies,
Zymeworks Inc.,
Admare Bioinnovations.
Notch Therapeutics's categories are Biotechnology Research
Notch Therapeutics's founding year is 2018
